Noom Med & GLP-1 Review 2026:
Is the Microdose Program Worth It?

If you’ve ever looked into weight loss apps, you know Noom. They revolutionized the psychology-based weight loss space. Now, they’ve entered the medication game with Noom Med and a highly advertised “Microdose” GLP-1 program. If you want to skip the deep dive and see if you qualify right now, you can take Noom’s 2-minute eligibility quiz here to see what your personalized plan looks like.

But before you sign up, you need to understand exactly what you are buying. The transition from a behavior-tracking app to a medical provider prescribing compounded semaglutide has been bumpy. Their pricing structure is complex, and the “Microdose” concept has generated a significant amount of debate and customer frustration.

After digging into their pricing structure, the clinical reality of microdosing, and hundreds of customer reviews, here is the complete, honest picture of the Noom GLP-1 program in 2026.

What Is Noom Med, Exactly?

Noom started as a behavioral health and weight loss app that focused on the psychology of eating. With Noom Med, they have added a telehealth clinic layer on top of their existing app infrastructure.

When you sign up for Noom Med, you are essentially buying two things: access to the Noom app (with its daily lessons, food tracking, and coaching) AND access to a medical provider who can prescribe weight loss medications, including compounded semaglutide.

Noom strongly emphasizes that medication alone is not enough, and that their program helps you “keep the muscle” and build habits so you can eventually stop taking the medication. This philosophy is reflected in their newest and most controversial offering: the Noom Microdose program.

How the Enrollment Process Works

Noom’s onboarding is heavily focused on data collection and behavioral profiling.

Noom Pricing: A Confusing Structure

Noom’s pricing is notoriously difficult to pin down because they constantly run promotions, bundle services differently, and charge based on the length of your commitment. However, here is the baseline structure for 2026.

The Standard Noom Med GLP-1 Program

If you want standard doses of compounded semaglutide (titrating up to the clinical maximums), the pricing is steep:

• Initial 3-week subscription + 4 weeks of medication: Starts at $149 (promotional)
• Ongoing cost: $299 per month (or up to $837 billed quarterly)

This puts Noom at the higher end of the compounded semaglutide market, tying them with Willow but significantly more expensive than OrderlyMeds or Mochi Health.

The Noom Microdose Program

This is Noom’s newest offering, designed to be a cheaper entry point:

• Initial 3 weeks: Starts at $119
• Ongoing cost: $199 per month

While $199/month sounds competitive, there is a massive catch: the maximum dose you can receive on the Microdose plan is 0.6mg of semaglutide per week. The standard clinical dose for weight loss (Wegovy) is 2.4mg. You are paying less, but you are getting a fraction of the medication.

The Microdose Controversy: Does It Actually Work?

The Microdose program has generated significant debate. Noom claims that by combining a low dose of medication (max 0.6mg) with their intense behavioral coaching, patients can lose weight while experiencing fewer side effects and preserving more muscle mass.

However, the clinical data for semaglutide shows that weight loss is dose-dependent. The majority of patients do not see significant weight loss until they reach doses of 1.0mg or higher. By capping the dose at 0.6mg, Noom is essentially relying on their app to do the heavy lifting.

This has led to a flood of negative reviews on Reddit. As one user noted: “Most negative reviews I see are complaining about the microdose. The microdose is known not to be effective without making healthy choices.” If you are paying $199/month, you are largely paying for the app and a very small amount of medication.

What Real Customers Are Saying

Noom has a massive user base, and their reviews reflect the tension between their excellent app and their struggling telehealth operations.

How Noom Compares to Competitors

Here is how Noom’s standard GLP-1 program stacks up against the market:

Our Final Verdict

Noom is a behavioral health company trying to be a pharmacy, and the seams are showing. If you are someone who struggles with emotional eating, needs intense psychological coaching, and wants medication simply as an adjunct to behavioral change, the Noom app ecosystem is unparalleled. You are paying a premium for the app, not the drug.

However, if your primary goal is to access effective doses of compounded semaglutide at a reasonable price, Noom is a poor choice. The Microdose program ($199/mo) caps your dose so low that many patients see no results, and the standard clinical program ($299/mo) is significantly more expensive than competitors like OrderlyMeds or Mochi Health. Combine that with widespread complaints about customer service, and Noom is best reserved only for patients who truly value their app experience above all else.